Ractigen Therapeutics Unveils saRNA Breakthrough for Obesity at ADA 2026
Beyond Appetite Suppression: The New Frontier of Metabolic Engineering For years, the gold standard for weight management has been the “incretin” revolution. Drugs like semaglutide have dominated the conversation by curbing appetite, but they have brought a troubling side effect: the loss of lean muscle mass. As the medical community looks toward the next generation … Read more